EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter randomized trial of intra venous/oral itraconazole vs intra venous/oral fluconazole for long-term antifungal prophylaxis in allogeneic bone marrow transplant patients



Multicenter randomized trial of intra venous/oral itraconazole vs intra venous/oral fluconazole for long-term antifungal prophylaxis in allogeneic bone marrow transplant patients



International Journal of Infectious Diseases 6(Supplement 2): 2S41, June




(PDF same-day service: $19.90)

Accession: 035349916

Download citation: RISBibTeXText

DOI: 10.1016/s1201-9712(02)90264-x



Related references

Long-term antifungal prophylaxis in allogeneic bone marrow transplant patients A multicenter, randomized trial of intravenous/oral itraconazole versus intravenous/oral fluconazole. Blood 98(11 Part 1): 479a, November 16, 2001

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Annals of Internal Medicine 138(9): 705-713, 2003

Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial. Transplant Infectious Disease 16(2): 286-294, 2015

Comparative study of oral nystatin and fluconazole as antifungal prophylaxis for pediatric bone marrow transplant patients. Clinical Research 40(4): 790A, 1992

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 96(6): 2055-2061, 2000

Itraconazole vs Fluconazole for Antifungal Prophylaxis in Allogeneic HSCT Recipients Results of a Randomized Trial. Blood 100(11): Abstract No 806, November 16, 2002

Itraconazole vs. fluconazole for antifungal prophylaxis in allogeneic stem-cell transplant patients. Clinical Microbiology and Infection 12(Suppl. 7): 91-96, 2006

Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients. Bone Marrow Transplantation 5(3): 179-182, 1990

Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infections. Pharmacoeconomics 8(4): 350-361, 1995

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Journal of Antimicrobial ChemoTherapy 57(2): 317-325, 2005

Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1. Transplantation Journal 74(5): 688-695, 2002

Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 74(5): 688-695, 2002

Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian Nurse Bone Marrow Transplant Group (GITMO). Haematologica 85(3): 275-279, 2000

Itraconazole oral solution vs fluconazole suspension for antifungal prophylaxis in neutropenic patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 286, 1996

Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation. Bone Marrow Transplantation 21(12): 1239-1243, June 2, 1998